Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 11912272)

1.

ACE inhibitors versus AT(1) receptor antagonists in patients with chronic renal disease.

Hilgers KF, Mann JF.

J Am Soc Nephrol. 2002 Apr;13(4):1100-8. Review. No abstract available.

2.

ACE inhibitors and AT1 receptor antagonists: is two better than one?

Noris M, Remuzzi G.

Kidney Int. 2002 Apr;61(4):1545-7. No abstract available.

4.
6.
7.

[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].

Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.

Presse Med. 2002 Nov 9;31(36):1714-20. Review. French.

PMID:
12467154
8.
9.

Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?

Hilgers KF, Dötsch J, Rascher W, Mann JF.

Pediatr Nephrol. 2004 Sep;19(9):956-61. Epub 2004 Jul 22. Review.

PMID:
15278690
10.
11.

[ACE and AT1 inhibitors in used in the progression of chronic renal failure].

Switalski M.

Pol Arch Med Wewn. 2002 Apr;107(4):379-87. Review. Polish. No abstract available.

PMID:
12189931
12.

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.

PMID:
16797382
13.
14.

The role of calcium antagonists in chronic kidney disease.

Gashti CN, Bakris GL.

Curr Opin Nephrol Hypertens. 2004 Mar;13(2):155-61. Review.

PMID:
15202609
15.

[Combination therapy with ACE inhibitors and angiotensin receptor antagonists].

Kisters K.

Internist (Berl). 1999 Jun;40(6):678-9. German. No abstract available.

PMID:
10420325
16.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.

Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.

Am Heart J. 2007 Jun;153(6):1064-73.

PMID:
17540211
17.

The reno-protective effect of the dual blockade of the renin angiotensin system (RAS).

Luno J, Praga M, de Vinuesa SG.

Curr Pharm Des. 2005;11(10):1291-300. Review.

PMID:
15853685
18.

Combination ACEI and ARB therapy: additional benefit in renoprotection?

Taal MW, Brenner BM.

Curr Opin Nephrol Hypertens. 2002 Jul;11(4):377-81. Review.

PMID:
12105385
19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk